1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Spinal Devices and Biologics Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Spinal Devices and Biologics by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Spinal Devices and Biologics by Country/Region, 2018, 2022 & 2029
2.2 Spinal Devices and Biologics Segment by Type
2.2.1 Spinal Fusion & Fixation
2.2.2 Motion Preservation
2.2.3 Non-Fusion Technologies
2.2.4 Fracture Treatment
2.2.5 Others
2.3 Spinal Devices and Biologics Sales by Type
2.3.1 Global Spinal Devices and Biologics Sales Market Share by Type (2018-2023)
2.3.2 Global Spinal Devices and Biologics Revenue and Market Share by Type (2018-2023)
2.3.3 Global Spinal Devices and Biologics Sale Price by Type (2018-2023)
2.4 Spinal Devices and Biologics Segment by Application
2.4.1 Hospitals
2.4.2 Ambulatory Surgical Centers
2.4.3 Clinics
2.4.4 Others
2.5 Spinal Devices and Biologics Sales by Application
2.5.1 Global Spinal Devices and Biologics Sale Market Share by Application (2018-2023)
2.5.2 Global Spinal Devices and Biologics Revenue and Market Share by Application (2018-2023)
2.5.3 Global Spinal Devices and Biologics Sale Price by Application (2018-2023)
3 Global Spinal Devices and Biologics by Company
3.1 Global Spinal Devices and Biologics Breakdown Data by Company
3.1.1 Global Spinal Devices and Biologics Annual Sales by Company (2018-2023)
3.1.2 Global Spinal Devices and Biologics Sales Market Share by Company (2018-2023)
3.2 Global Spinal Devices and Biologics Annual Revenue by Company (2018-2023)
3.2.1 Global Spinal Devices and Biologics Revenue by Company (2018-2023)
3.2.2 Global Spinal Devices and Biologics Revenue Market Share by Company (2018-2023)
3.3 Global Spinal Devices and Biologics Sale Price by Company
3.4 Key Manufacturers Spinal Devices and Biologics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Spinal Devices and Biologics Product Location Distribution
3.4.2 Players Spinal Devices and Biologics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Spinal Devices and Biologics by Geographic Region
4.1 World Historic Spinal Devices and Biologics Market Size by Geographic Region (2018-2023)
4.1.1 Global Spinal Devices and Biologics Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Spinal Devices and Biologics Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Spinal Devices and Biologics Market Size by Country/Region (2018-2023)
4.2.1 Global Spinal Devices and Biologics Annual Sales by Country/Region (2018-2023)
4.2.2 Global Spinal Devices and Biologics Annual Revenue by Country/Region (2018-2023)
4.3 Americas Spinal Devices and Biologics Sales Growth
4.4 APAC Spinal Devices and Biologics Sales Growth
4.5 Europe Spinal Devices and Biologics Sales Growth
4.6 Middle East & Africa Spinal Devices and Biologics Sales Growth
5 Americas
5.1 Americas Spinal Devices and Biologics Sales by Country
5.1.1 Americas Spinal Devices and Biologics Sales by Country (2018-2023)
5.1.2 Americas Spinal Devices and Biologics Revenue by Country (2018-2023)
5.2 Americas Spinal Devices and Biologics Sales by Type
5.3 Americas Spinal Devices and Biologics Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Spinal Devices and Biologics Sales by Region
6.1.1 APAC Spinal Devices and Biologics Sales by Region (2018-2023)
6.1.2 APAC Spinal Devices and Biologics Revenue by Region (2018-2023)
6.2 APAC Spinal Devices and Biologics Sales by Type
6.3 APAC Spinal Devices and Biologics Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Spinal Devices and Biologics by Country
7.1.1 Europe Spinal Devices and Biologics Sales by Country (2018-2023)
7.1.2 Europe Spinal Devices and Biologics Revenue by Country (2018-2023)
7.2 Europe Spinal Devices and Biologics Sales by Type
7.3 Europe Spinal Devices and Biologics Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Spinal Devices and Biologics by Country
8.1.1 Middle East & Africa Spinal Devices and Biologics Sales by Country (2018-2023)
8.1.2 Middle East & Africa Spinal Devices and Biologics Revenue by Country (2018-2023)
8.2 Middle East & Africa Spinal Devices and Biologics Sales by Type
8.3 Middle East & Africa Spinal Devices and Biologics Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Spinal Devices and Biologics
10.3 Manufacturing Process Analysis of Spinal Devices and Biologics
10.4 Industry Chain Structure of Spinal Devices and Biologics
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Spinal Devices and Biologics Distributors
11.3 Spinal Devices and Biologics Customer
12 World Forecast Review for Spinal Devices and Biologics by Geographic Region
12.1 Global Spinal Devices and Biologics Market Size Forecast by Region
12.1.1 Global Spinal Devices and Biologics Forecast by Region (2024-2029)
12.1.2 Global Spinal Devices and Biologics Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Spinal Devices and Biologics Forecast by Type
12.7 Global Spinal Devices and Biologics Forecast by Application
13 Key Players Analysis
13.1 Nuvasive
13.1.1 Nuvasive Company Information
13.1.2 Nuvasive Spinal Devices and Biologics Product Portfolios and Specifications
13.1.3 Nuvasive Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Nuvasive Main Business Overview
13.1.5 Nuvasive Latest Developments
13.2 Orthofix International
13.2.1 Orthofix International Company Information
13.2.2 Orthofix International Spinal Devices and Biologics Product Portfolios and Specifications
13.2.3 Orthofix International Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Orthofix International Main Business Overview
13.2.5 Orthofix International Latest Developments
13.3 Exactech
13.3.1 Exactech Company Information
13.3.2 Exactech Spinal Devices and Biologics Product Portfolios and Specifications
13.3.3 Exactech Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Exactech Main Business Overview
13.3.5 Exactech Latest Developments
13.4 Wright Medical Group
13.4.1 Wright Medical Group Company Information
13.4.2 Wright Medical Group Spinal Devices and Biologics Product Portfolios and Specifications
13.4.3 Wright Medical Group Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Wright Medical Group Main Business Overview
13.4.5 Wright Medical Group Latest Developments
13.5 Johnson & Johnson
13.5.1 Johnson & Johnson Company Information
13.5.2 Johnson & Johnson Spinal Devices and Biologics Product Portfolios and Specifications
13.5.3 Johnson & Johnson Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Johnson & Johnson Main Business Overview
13.5.5 Johnson & Johnson Latest Developments
13.6 Zimmer Biomet
13.6.1 Zimmer Biomet Company Information
13.6.2 Zimmer Biomet Spinal Devices and Biologics Product Portfolios and Specifications
13.6.3 Zimmer Biomet Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Zimmer Biomet Main Business Overview
13.6.5 Zimmer Biomet Latest Developments
13.7 Globus Medical
13.7.1 Globus Medical Company Information
13.7.2 Globus Medical Spinal Devices and Biologics Product Portfolios and Specifications
13.7.3 Globus Medical Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Globus Medical Main Business Overview
13.7.5 Globus Medical Latest Developments
13.8 K2M
13.8.1 K2M Company Information
13.8.2 K2M Spinal Devices and Biologics Product Portfolios and Specifications
13.8.3 K2M Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 K2M Main Business Overview
13.8.5 K2M Latest Developments
13.9 Medtronic
13.9.1 Medtronic Company Information
13.9.2 Medtronic Spinal Devices and Biologics Product Portfolios and Specifications
13.9.3 Medtronic Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Medtronic Main Business Overview
13.9.5 Medtronic Latest Developments
13.10 Alphatec Holdings
13.10.1 Alphatec Holdings Company Information
13.10.2 Alphatec Holdings Spinal Devices and Biologics Product Portfolios and Specifications
13.10.3 Alphatec Holdings Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Alphatec Holdings Main Business Overview
13.10.5 Alphatec Holdings Latest Developments
13.11 RTI Surgical
13.11.1 RTI Surgical Company Information
13.11.2 RTI Surgical Spinal Devices and Biologics Product Portfolios and Specifications
13.11.3 RTI Surgical Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 RTI Surgical Main Business Overview
13.11.5 RTI Surgical Latest Developments
14 Research Findings and Conclusion
| ※参考情報 脊椎装置および生物製剤は、脊椎に関連する疾患や損傷の治療に用いられる医療技術や製品を指します。近年、脊椎の疾患は高齢化社会の進展や生活習慣の変化に伴い増加しており、これに対応するための治療法や装置の開発が求められています。脊椎装置と生物製剤の両者は、外科手術や非手術的治療法の一環として重要な役割を果たしています。 脊椎装置の概念は、主に手術において脊椎の安定性を保つための機器を指します。これらの装置は、骨折や変性疾患、脊椎の異常を改善するために使用されます。脊椎装置の特徴には、高い強度や耐久性が求められることが挙げられます。これらは通常チタンやステンレススチールなどの生体適合材料から作られており、患者の体内で長期間使用されることが前提です。また、術後の回復を促進し、痛みを軽減するための工夫が凝らされています。 脊椎装置にはさまざまな種類があり、一部を以下に示します。まず、インプラントとしては、スクリューやロッド、プレートなどの固定具があります。これらは脊椎の骨を固定し、手術後の安定性を確保するために用いられます。また、椎間板置換術では、損傷した椎間板を人工物に置き換えるための装置も含まれます。さらに、脊椎の変形を矯正するための器具や、椎間孔を拡大するための道具も存在します。 生物製剤は、主に生体由来の材料を使用して、脊椎治療における再生や修復を目的とした製品群です。生物製剤の特徴として、生体適合性が非常に重要視されます。これらの製剤は、患者の組織に自然に接触し、拒絶反応を示さないように設計されています。生物製剤には、成長因子や細胞療法を活用した製品が含まれ、これにより骨形成や組織再生を促進します。 生物製剤の種類としては、再生医療に用いられる骨補填材や、細胞ベースの治療法などが挙げられます。骨補填材は、骨の損傷や欠損を修復するために使用され、主にコラーゲンやハイドロキシアパタイトなどの材料が用いられます。成長因子を含む生物製剤は、骨の形成を促進し、傷の治癒を早める効果があります。さらに、幹細胞を利用した治療法も注目されており、これにより脊椎の損傷を修復する新たなアプローチが模索されています。 脊椎装置と生物製剤の用途は多岐にわたります。たとえば、脊椎の固定術や椎間板ヘルニア手術においては、脊椎装置が主要な役割を果たします。これにより、脊椎の安定性を確保し、痛みの軽減を図ります。生物製剤は、これらの手術後の回復を促進するために用いられることが多く、骨の再生や組織の修復を助けます。さらに、慢性的な腰痛や脊椎の変性疾患に対する治療方法としても、生物製剤の投与が検討されています。 関連技術としては、医療機器の改良に向けた3Dプリンティング技術があります。この技術により、個々の患者に最適化された脊椎装置の製造が可能となり、より適切な治療が期待されています。また、ナビゲーションシステムやロボティクスを用いた手術サポートが進化しており、これにより手術の精度や安全性が向上しています。 脊椎装置と生物製剤は、今後ますます重要な領域となるでしょう。これにより、患者の生活の質を向上させるための新しい治療法が開発され続けることが期待されています。技術革新とともに、脊椎装置と生物製剤の研究や応用が進むことで、より多くの患者が恩恵を受けることができると考えられています。治療法の選択肢は広がり、脊椎疾患に苦しむ多くの人々にとって希望がもたらされるのです。 |
